Venture Life Dividends - VLG

Venture Life Dividends - VLG

Buy
Sell
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Venture Life Group Plc VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 87.00 08:00:00
Open Price Low Price High Price Close Price Previous Close
87.00 87.00 87.00 87.00 87.00
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Venture Life VLG Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
22/03/2018FinalGBX0.0431/12/201631/12/201724/05/201825/05/201822/06/20180.04
23/03/2017FinalGBX0.0431/12/201531/12/201625/05/201726/05/201723/06/20170.04
04/05/2016FinalGBX0.0431/12/201431/12/201526/05/201627/05/201624/06/20160.04
15/04/2015FinalGBX0.0431/12/201331/12/201421/05/201522/05/201519/06/20150.04

Top Dividend Posts

DateSubject
26/3/2021
08:27
qs99: Thanks Riv.....does it give a TP? No worries if not. I'm more EV/EBITDA ratio value hunter really.....but it is a strong note IMO and thanks for sharing. Good they have bolstered the M&A team. Mind you in my day at a PLC we managed to do plenty in one year with a minimal team (me!)....so VLG are behind the curve on timing IMO still.... DYOR
25/3/2021
08:53
melody9999: The market has priced in the lack of acquisition news since the funding - IMV excessively. But that provides a buying opportunity AFAIAC. A deal is never done until is done, and assuming you trust the VLG management then IMV you cannot blame them for that - rather kudos for not rushing into a poor deal In the meantime, and in any case, we have a business that is growing stongly organically ......with kickers likely to come from acquisitions. Whats not to like? Added this am
23/3/2021
07:17
rivaldo: Good news for VLG from Alliance Pharma's 2020 results today - APH did OK overall, but Kelo-cote outperformed, particularly from Q2 onwards (which was when VLG began production): "Kelo-cote - scar prevention and treatment We were particularly pleased with the performance of Kelo-cote, which delivered good growth in 2020, continuing the trend from 2019, with sales up 12% to GBP34.7m (2019: GBP31.0m), due to further strong demand from China from the second quarter onwards as local lockdown restrictions eased. Across the rest of the APAC region, ongoing local lockdown restrictions in response to the pandemic have had a more sustained impact on the brand's performance, likewise in South America and some countries within EMEA. Nevertheless, we expect sales across all these regions to return strongly once lockdown restrictions are eased."
03/3/2021
10:15
red ninja: The company is also doing a InvestorMeetCompany webinar. I am not sure why they would want to do that if they don't think there is a reasonable story to sell. https://www.investegate.co.uk/venture-life-group--vlg-/rns/investor-presentation/202102250700042439Q/
03/3/2021
10:12
red ninja: The RNS says the placing price was 90p is that not correct ? https://www.investegate.co.uk/venture-life-group--vlg-/rns/placing--open-offer-and-notice-of-general-meeting/202011201300010547G/
02/3/2021
12:59
farnesbarnes: I find it disconcerting that ST hasn't mentioned VLG recently either. The dynamics of the company changed significantly with the corporate action.
02/3/2021
12:58
qs99: 3 weeks before the results no? Will we see any buying interest ahead of them? Will they finally have completed a deal? Maddening drift in the shares, so let's hope VLG board have something positive to say/report
01/2/2021
11:03
simon gordon: Disco, If/when VLG do an acquisition Cenkos will update their forecast. As it stands today Cenkos forecast 14x ex-cash and net cash of £36.3m. When VLG do an acquisition they will update their p/e and cash forecast. If you follow this link you will find a way to access the Cenkos note published this morning: Https://www.venture-life.com/investor-relations/analysts/
01/2/2021
09:53
rivaldo: Agreed QS99. I'm happy to stay invested here for considerable upside. N+1 Singer this morning presently have a 114p fair value target here. Worth noting that they see a £35.5m cash pile at 31st December just gone - 32% of the current m/cap. They forecast 3.2p EPS for the current year, so if you strip out the cash that's a current year ex-cash P/E of around 18 or 19. And that EPS forecast includes a conservative reduction in terms of forecast Chinese sales balanced out by increasing growth in VLG's other core markets and products. When VLG eventually conclude any or all of their three mooted acquisitions, then the earnings-enhancing aspects will likely bring that P/E down substantially.
20/11/2020
09:07
rivaldo: Good to see VLG newly tipped on Investors' Champion - subscriber-only though: Https://www.investorschampion.com/channel/blog/a-reasonably-valued-healthcare-company-surely-there-must-be-a-catch "A reasonably valued healthcare company, there must be a catch! (Updated) 18/11/2020 · Venture Life Group PLC (VLG) Many healthcare companies, especially with anything relating to aiding Covid-19, have benefited from a strong share price over the pandemic and it is rare to find something of seemingly reasonable value. The shares received another boost on news that its mouthwash might be effective against COVID-19. Check out our updated research here. Founded in 2010, Venture Life Group (LON:VLG) is an international consumer healthcare company focused on developing and manufacturing non-drug self-care products for the ageing population, which consumers can buy without prescription. The Group's manufacturing is based in Italy, where a 5,500m² factory is being expanded to produce up to 55 million units per annum by the end of the year, producing both Venture Life's own brands as well as products for others as a contract manufacturer. With over 35 years of experience, the site boasts exciting development capabilities thanks to superior laboratory facilities and knowledge of the market. The Group has 10 branded products, covering…"
ADVFN Advertorial
Your Recent History
LSE
VLG
Venture Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210410 21:51:13